# Lived Experience of Extracorporeal Membrane Oxygenation Survivors: A Phenomenological Study

**Authors:** Meng Zhang, Anqi Sun, Anqi Yu, Juan Deng, Yi Wang, Xiao Cheng, Jie Xiong

PMC · DOI: 10.1111/nicc.70341 · Nursing in Critical Care · 2026-02-01

## TL;DR

This study explores the physical, emotional, and social challenges faced by survivors of ECMO treatment to improve their quality of life and recovery.

## Contribution

The paper provides a multidimensional qualitative analysis of ECMO survivors' lived experiences, highlighting unmet needs and emotional challenges.

## Key findings

- ECMO survivors face physical limitations, long-term complications, and lifestyle adjustments.
- Emotional distress and psychological challenges are common, requiring targeted support.
- Survivors desire expanded insurance coverage, rehabilitation knowledge, and simplified follow-up procedures.

## Abstract

Extracorporeal membrane oxygenation (ECMO) is a vital extracorporeal life support for acute cardiopulmonary failure, serving as a critical lifesaving measure widely utilised during the COVID‐19 pandemic. Despite the enhancement of survival rates and the extension of its utilisation, ECMO survivors face complications and post‐discharge challenges. Understanding their lived experience is crucial to promote nursing quality improvement and improve their health‐related quality of life (HRQoL).

To explore the lived experiences of ECMO survivors.

A phenomenological study was conducted among patients who had survived ECMO treatment at Tongji Hospital in Wuhan between 2013 and 2023. Interview guides and data analysis were informed by the biopsychosocial medical model. The interview data were analysed using the Giorgi data analysis method.

In total, 16 ECMO survivors participated. Three themes and 12 sub‐themes emerged: (1) Living conditions and challenges (physical limitations, long‐term effects of complications, lifestyle adjustments, self‐rehabilitation and exercise, family economic burden); (2) Emotional distress and support (emotional difficulties and psychological challenges, emotion management and support perception); (3) Expectations and needs (desire for expanded insurance reimbursement, eagerness for rehabilitation knowledge, hope for simplified follow‐up procedures and normalisation of regular follow‐up).

ECMO survivors face multiple challenges and needs during their recovery. To improve their HRQoL and well‐being, healthcare providers should closely monitor the psychological status, pay attention to their complaints and feelings, and provide targeted nursing guidance and multidimensional social support.

The lived experience of ECMO survivors is complex and their rehabilitation is a long process requiring comprehensive support to assist them in better integrating into society.

What is known about the subject
○ECMO is a vital life support technology increasingly used in clinical practice, significantly improving survival rates among patients with severe cardiopulmonary failure.○ECMO survivors often experience long‐term physical, emotional and cognitive challenges that impair their HRQoL.○Existing research has predominantly focused on clinical outcomes and mortality predictors, with limited qualitative insight into patients' lived experiences post‐ECMO.
What the paper adds
○This study provides an in‐depth, multidimensional exploration of the lived experiences of ECMO survivors.○It identifies key themes such as emotional adaptation, persistent physical limitations and the needs for structured post‐discharge support.○The findings offer evidence‐based implications for developing tailored rehabilitation programs and continuous care models to improve long‐term recovery and HRQoL for ECMO survivors.

What is known about the subject
○ECMO is a vital life support technology increasingly used in clinical practice, significantly improving survival rates among patients with severe cardiopulmonary failure.○ECMO survivors often experience long‐term physical, emotional and cognitive challenges that impair their HRQoL.○Existing research has predominantly focused on clinical outcomes and mortality predictors, with limited qualitative insight into patients' lived experiences post‐ECMO.

ECMO is a vital life support technology increasingly used in clinical practice, significantly improving survival rates among patients with severe cardiopulmonary failure.

ECMO survivors often experience long‐term physical, emotional and cognitive challenges that impair their HRQoL.

Existing research has predominantly focused on clinical outcomes and mortality predictors, with limited qualitative insight into patients' lived experiences post‐ECMO.

What the paper adds
○This study provides an in‐depth, multidimensional exploration of the lived experiences of ECMO survivors.○It identifies key themes such as emotional adaptation, persistent physical limitations and the needs for structured post‐discharge support.○The findings offer evidence‐based implications for developing tailored rehabilitation programs and continuous care models to improve long‐term recovery and HRQoL for ECMO survivors.

This study provides an in‐depth, multidimensional exploration of the lived experiences of ECMO survivors.

It identifies key themes such as emotional adaptation, persistent physical limitations and the needs for structured post‐discharge support.

The findings offer evidence‐based implications for developing tailored rehabilitation programs and continuous care models to improve long‐term recovery and HRQoL for ECMO survivors.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** PTSD (MESH:D013313), cognitive or psychiatric disorders (MESH:D001523), cardiopulmonary failure (MESH:D051437), cardiogenic shock (MESH:D012770), stroke (MESH:D020521), acute cardiopulmonary failure (MESH:D058186), leg injuries (MESH:D007869), haemorrhage (MESH:D006470), respiratory failure (MESH:D012131), Cancer (MESH:D009369), neurological impairment (MESH:D009422), chronic pain (MESH:D059350), ECMO (MESH:D000860), injuries (MESH:D014947), cognitive impairment (MESH:D003072), lump (MESH:C536531), muscle weakness (MESH:D018908), COVID-19 (MESH:D000086382), memory deficits (MESH:D008569), neurological damage (MESH:D020196), illness (MESH:D002908), itching (MESH:D011537), heart problems (MESH:D006331), emotional disturbances (MESH:D014832), pain (MESH:D010146)
- **Chemicals:** Rigour (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862116/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862116/full.md

---
Source: https://tomesphere.com/paper/PMC12862116